UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME
Sales, net	$ 10,400	$ 12,866	$ 21,740	$ 25,386
Cost of goods sold	4,147	5,127	8,722	9,805
Gross profit	6,253	7,739	13,018	15,581
Operating expense
Selling, general and administrative	2,560	3,181	5,176	6,440
Research & development	255	133	521	277
Total operating expenses	2,815	3,314	5,697	6,717
Operating income	3,438	4,425	7,321	8,864
Other income	773	747	1,689	1,428
Income before provision for income taxes	4,211	5,172	9,010	10,292
Provision for income taxes	758	972	1,601	1,878
Net income	$ 3,453	$ 4,200	$ 7,409	$ 8,414
Earnings per common share (basic)	$ 0.98	$ 1.16	$ 2.07	$ 2.32
Earnings per common share (diluted)	$ 0.98	$ 1.15	$ 2.07	$ 2.31
Shares outstanding - basic	3,532	3,628	3,579	3,628
Shares outstanding - diluted	3,532	3,639	3,579	3,638
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ (33)	$ 504	$ (664)	$ 1,053
Total comprehensive income	$ 3,420	$ 4,704	$ 6,745	$ 9,467